data_P0T
#
_chem_comp.id P0T
_chem_comp.name cannabidiol
_chem_comp.type NON-POLYMER
_chem_comp.pdbx_type HETAIN
_chem_comp.formula "C21 H30 O2"
_chem_comp.mon_nstd_parent_comp_id ?
_chem_comp.pdbx_synonyms
"(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol"
_chem_comp.pdbx_formal_charge 0
_chem_comp.pdbx_initial_date 2019-01-16
_chem_comp.pdbx_modified_date 2021-03-13
_chem_comp.pdbx_ambiguous_flag N
_chem_comp.pdbx_release_status REL
_chem_comp.pdbx_replaced_by ?
_chem_comp.pdbx_replaces ?
_chem_comp.formula_weight 314.462
_chem_comp.one_letter_code ?
_chem_comp.three_letter_code P0T
_chem_comp.pdbx_model_coordinates_details ?
_chem_comp.pdbx_model_coordinates_missing_flag N
_chem_comp.pdbx_ideal_coordinates_details Corina
_chem_comp.pdbx_ideal_coordinates_missing_flag N
_chem_comp.pdbx_model_coordinates_db_code 6NNM
_chem_comp.pdbx_subcomponent_list ?
_chem_comp.pdbx_processing_site RCSB
#
loop_
_chem_comp_atom.comp_id
_chem_comp_atom.atom_id
_chem_comp_atom.alt_atom_id
_chem_comp_atom.type_symbol
_chem_comp_atom.charge
_chem_comp_atom.pdbx_align
_chem_comp_atom.pdbx_aromatic_flag
_chem_comp_atom.pdbx_leaving_atom_flag
_chem_comp_atom.pdbx_stereo_config
_chem_comp_atom.pdbx_backbone_atom_flag
_chem_comp_atom.pdbx_n_terminal_atom_flag
_chem_comp_atom.pdbx_c_terminal_atom_flag
_chem_comp_atom.model_Cartn_x
_chem_comp_atom.model_Cartn_y
_chem_comp_atom.model_Cartn_z
_chem_comp_atom.pdbx_model_Cartn_x_ideal
_chem_comp_atom.pdbx_model_Cartn_y_ideal
_chem_comp_atom.pdbx_model_Cartn_z_ideal
_chem_comp_atom.pdbx_component_atom_id
_chem_comp_atom.pdbx_component_comp_id
_chem_comp_atom.pdbx_ordinal
P0T C10 C1 C 0 1 N N N N N N 159.860 142.330 172.892 -1.945 2.286 -0.570 C10 P0T 1
P0T C11 C2 C 0 1 Y N N N N N 159.674 139.387 169.859 0.055 0.181 1.611 C11 P0T 2
P0T C12 C3 C 0 1 Y N N N N N 157.636 139.288 171.123 -0.209 -0.993 -0.466 C12 P0T 3
P0T C13 C4 C 0 1 N N N N N N 157.273 143.790 167.971 -4.789 -2.694 -0.020 C13 P0T 4
P0T C14 C5 C 0 1 N N N N N N 158.801 143.116 173.697 -2.352 3.188 0.567 C14 P0T 5
P0T C03 C6 C 0 1 N N R N N N 159.796 142.331 171.363 -2.545 0.910 -0.692 C03 P0T 6
P0T C04 C7 C 0 1 N N R N N N 158.549 141.565 170.888 -2.221 0.094 0.562 C04 P0T 7
P0T C05 C8 C 0 1 N N N N N N 159.753 143.819 171.000 -4.069 1.021 -0.822 C05 P0T 8
P0T C06 C9 C 0 1 N N N N N N 159.401 144.060 169.526 -4.633 -0.370 -1.122 C06 P0T 9
P0T C07 C10 C 0 1 N N N N N N 157.955 142.104 169.590 -3.024 -1.173 0.577 C07 P0T 10
P0T C08 C11 C 0 1 Y N N N N N 158.679 140.042 170.609 -0.753 -0.248 0.569 C08 P0T 11
P0T C09 C12 C 0 1 N N N N N N 158.090 143.354 169.202 -4.079 -1.372 -0.152 C09 P0T 12
P0T C15 C13 C 0 1 Y N N N N N 158.557 137.256 170.238 1.946 -0.878 0.583 C15 P0T 13
P0T C16 C14 C 0 1 Y N N N N N 159.609 137.996 169.687 1.406 -0.136 1.615 C16 P0T 14
P0T C17 C15 C 0 1 Y N N N N N 157.563 137.909 170.955 1.143 -1.308 -0.456 C17 P0T 15
P0T C18 C16 C 0 1 N N N N N N 158.455 135.719 170.062 3.414 -1.221 0.590 C18 P0T 16
P0T C19 C17 C 0 1 N N N N N N 160.833 141.679 173.524 -1.073 2.701 -1.455 C19 P0T 17
P0T C20 C18 C 0 1 N N N N N N 156.997 135.381 169.646 4.197 -0.122 -0.131 C20 P0T 18
P0T C21 C19 C 0 1 N N N N N N 156.786 133.845 169.612 5.687 -0.470 -0.123 C21 P0T 19
P0T C22 C20 C 0 1 N N N N N N 157.734 133.214 168.564 6.471 0.629 -0.844 C22 P0T 20
P0T C23 C21 C 0 1 N N N N N N 157.418 131.712 168.376 7.961 0.281 -0.837 C23 P0T 21
P0T O01 O1 O 0 1 N N N N N N 160.760 140.063 169.278 -0.475 0.916 2.624 O01 P0T 22
P0T O02 O2 O 0 1 N N N N N N 156.643 139.957 171.841 -0.998 -1.415 -1.488 O02 P0T 23
P0T H1 H1 H 0 1 N N N N N N 156.365 143.174 167.896 -4.369 -3.405 -0.731 H1 P0T 24
P0T H2 H2 H 0 1 N N N N N N 156.990 144.848 168.075 -4.662 -3.075 0.993 H2 P0T 25
P0T H3 H3 H 0 1 N N N N N N 157.880 143.660 167.063 -5.851 -2.559 -0.227 H3 P0T 26
P0T H4 H4 H 0 1 N N N N N N 159.000 143.004 174.773 -3.214 3.785 0.266 H4 P0T 27
P0T H5 H5 H 0 1 N N N N N N 158.849 144.181 173.424 -2.615 2.583 1.434 H5 P0T 28
P0T H6 H6 H 0 1 N N N N N N 157.800 142.723 173.467 -1.524 3.849 0.821 H6 P0T 29
P0T H7 H7 H 0 1 N N N N N N 160.703 141.867 170.947 -2.138 0.409 -1.570 H7 P0T 30
P0T H8 H8 H 0 1 N N N N N N 157.783 141.682 171.669 -2.459 0.683 1.448 H8 P0T 31
P0T H9 H9 H 0 1 N N N N N N 160.741 144.259 171.202 -4.491 1.394 0.111 H9 P0T 32
P0T H10 H10 H 0 1 N N N N N N 158.996 144.312 171.628 -4.318 1.704 -1.635 H10 P0T 33
P0T H11 H11 H 0 1 N N N N N N 160.202 143.660 168.886 -5.719 -0.345 -1.037 H11 P0T 34
P0T H12 H12 H 0 1 N N N N N N 159.292 145.140 169.346 -4.357 -0.660 -2.136 H12 P0T 35
P0T H13 H13 H 0 1 N N N N N N 157.397 141.427 168.960 -2.705 -1.967 1.235 H13 P0T 36
P0T H16 H16 H 0 1 N N N N N N 160.379 137.491 169.123 2.036 0.198 2.427 H16 P0T 37
P0T H17 H17 H 0 1 N N N N N N 156.741 137.351 171.378 1.567 -1.887 -1.263 H17 P0T 38
P0T H18 H18 H 0 1 N N N N N N 158.699 135.217 171.010 3.763 -1.301 1.619 H18 P0T 39
P0T H19 H19 H 0 1 N N N N N N 159.153 135.385 169.280 3.567 -2.171 0.079 H19 P0T 40
P0T H20 H20 H 0 1 N N N N N N 160.884 141.699 174.603 -0.646 3.690 -1.370 H20 P0T 41
P0T H21 H21 H 0 1 N N N N N N 161.572 141.131 172.958 -0.780 2.055 -2.269 H21 P0T 42
P0T H22 H22 H 0 1 N N N N N N 156.800 135.796 168.647 3.848 -0.042 -1.160 H22 P0T 43
P0T H23 H23 H 0 1 N N N N N N 156.301 135.826 170.372 4.043 0.828 0.380 H23 P0T 44
P0T H24 H24 H 0 1 N N N N N N 155.743 133.625 169.342 6.037 -0.550 0.906 H24 P0T 45
P0T H25 H25 H 0 1 N N N N N N 157.005 133.423 170.604 5.841 -1.421 -0.634 H25 P0T 46
P0T H26 H26 H 0 1 N N N N N N 158.774 133.324 168.905 6.122 0.709 -1.874 H26 P0T 47
P0T H27 H27 H 0 1 N N N N N N 157.606 133.733 167.603 6.317 1.579 -0.334 H27 P0T 48
P0T H28 H28 H 0 1 N N N N N N 158.102 131.284 167.628 8.519 1.064 -1.350 H28 P0T 49
P0T H29 H29 H 0 1 N N N N N N 157.547 131.188 169.334 8.310 0.201 0.192 H29 P0T 50
P0T H30 H30 H 0 1 N N N N N N 156.380 131.596 168.032 8.115 -0.669 -1.348 H30 P0T 51
P0T H31 H31 H 0 1 N N N N N N 160.691 140.992 169.464 -0.807 0.387 3.362 H31 P0T 52
P0T H32 H32 H 0 1 N N N N N N 155.991 139.333 172.137 -1.051 -0.794 -2.227 H32 P0T 53
#
loop_
_chem_comp_bond.comp_id
_chem_comp_bond.atom_id_1
_chem_comp_bond.atom_id_2
_chem_comp_bond.value_order
_chem_comp_bond.pdbx_aromatic_flag
_chem_comp_bond.pdbx_stereo_config
_chem_comp_bond.pdbx_ordinal
P0T C13 C09 SING N N 1
P0T C23 C22 SING N N 2
P0T C22 C21 SING N N 3
P0T C09 C06 SING N N 4
P0T C09 C07 DOUB N N 5
P0T O01 C11 SING N N 6
P0T C06 C05 SING N N 7
P0T C07 C04 SING N N 8
P0T C21 C20 SING N N 9
P0T C20 C18 SING N N 10
P0T C16 C11 DOUB Y N 11
P0T C16 C15 SING Y N 12
P0T C11 C08 SING Y N 13
P0T C18 C15 SING N N 14
P0T C15 C17 DOUB Y N 15
P0T C08 C04 SING N N 16
P0T C08 C12 DOUB Y N 17
P0T C04 C03 SING N N 18
P0T C17 C12 SING Y N 19
P0T C05 C03 SING N N 20
P0T C12 O02 SING N N 21
P0T C03 C10 SING N N 22
P0T C10 C19 DOUB N N 23
P0T C10 C14 SING N N 24
P0T C13 H1 SING N N 25
P0T C13 H2 SING N N 26
P0T C13 H3 SING N N 27
P0T C14 H4 SING N N 28
P0T C14 H5 SING N N 29
P0T C14 H6 SING N N 30
P0T C03 H7 SING N N 31
P0T C04 H8 SING N N 32
P0T C05 H9 SING N N 33
P0T C05 H10 SING N N 34
P0T C06 H11 SING N N 35
P0T C06 H12 SING N N 36
P0T C07 H13 SING N N 37
P0T C16 H16 SING N N 38
P0T C17 H17 SING N N 39
P0T C18 H18 SING N N 40
P0T C18 H19 SING N N 41
P0T C19 H20 SING N N 42
P0T C19 H21 SING N N 43
P0T C20 H22 SING N N 44
P0T C20 H23 SING N N 45
P0T C21 H24 SING N N 46
P0T C21 H25 SING N N 47
P0T C22 H26 SING N N 48
P0T C22 H27 SING N N 49
P0T C23 H28 SING N N 50
P0T C23 H29 SING N N 51
P0T C23 H30 SING N N 52
P0T O01 H31 SING N N 53
P0T O02 H32 SING N N 54
#
loop_
_pdbx_chem_comp_descriptor.comp_id
_pdbx_chem_comp_descriptor.type
_pdbx_chem_comp_descriptor.program
_pdbx_chem_comp_descriptor.program_version
_pdbx_chem_comp_descriptor.descriptor
P0T SMILES ACDLabs 12.01 C(=C)(\C)C1C(C=C(C)CC1)c2c(cc(cc2O)CCCCC)O
P0T InChI InChI 1.03 InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
P0T InChIKey InChI 1.03 QHMBSVQNZZTUGM-ZWKOTPCHSA-N
P0T SMILES_CANONICAL CACTVS 3.385 CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)=C)c(O)c1
P0T SMILES CACTVS 3.385 CCCCCc1cc(O)c([CH]2C=C(C)CC[CH]2C(C)=C)c(O)c1
P0T SMILES_CANONICAL "OpenEye OEToolkits" 2.0.6 CCCCCc1cc(c(c(c1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
P0T SMILES "OpenEye OEToolkits" 2.0.6 CCCCCc1cc(c(c(c1)O)C2C=C(CCC2C(=C)C)C)O
#
loop_
_pdbx_chem_comp_identifier.comp_id
_pdbx_chem_comp_identifier.type
_pdbx_chem_comp_identifier.program
_pdbx_chem_comp_identifier.program_version
_pdbx_chem_comp_identifier.identifier
P0T "SYSTEMATIC NAME" ACDLabs 12.01 "(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol"
P0T "SYSTEMATIC NAME" "OpenEye OEToolkits" 2.0.6 2-[(1~{R},6~{R})-3-methyl-6-prop-1-en-2-yl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol
#
loop_
_pdbx_chem_comp_audit.comp_id
_pdbx_chem_comp_audit.action_type
_pdbx_chem_comp_audit.date
_pdbx_chem_comp_audit.processing_site
P0T 'Create component' 2019-01-16 RCSB
P0T 'Initial release' 2019-10-16 RCSB
P0T 'Modify synonyms' 2021-03-13 RCSB
#
_pdbx_chem_comp_synonyms.ordinal 1
_pdbx_chem_comp_synonyms.comp_id P0T
_pdbx_chem_comp_synonyms.name
"(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol"
_pdbx_chem_comp_synonyms.provenance PDB
_pdbx_chem_comp_synonyms.type ?
#
_pdbe_chem_comp_drugbank_details.comp_id P0T
_pdbe_chem_comp_drugbank_details.drugbank_id DB09061
_pdbe_chem_comp_drugbank_details.type 'small molecule'
_pdbe_chem_comp_drugbank_details.name Cannabidiol
_pdbe_chem_comp_drugbank_details.description
;Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investigated, CBD has shown promise as a therapeutic and pharmaceutical drug target. In particular, CBD has shown promise as an analgesic, anticonvulsant, muscle relaxant, anxiolytic, antipsychotic and has shown neuroprotective, anti-inflammatory, and antioxidant activity, among other currently investigated uses [A32477, A32469]. CBD's exact place within medical practice is still currently hotly debated, however as the body of evidence grows and legislation changes to reflect its wide-spread use, public and medical opinion have changed significantly with regards to its usefulness in a number of medical conditions ranging from anxiety to epilepsy.  From a pharmacological perspective, Cannabis' (and CBD's) diverse receptor profile explains its potential application for such a wide variety of medical conditions. Cannabis contains more than 400 different chemical compounds, of which 61 are considered cannabinoids, a class of compounds that act upon endogenous cannabinoid receptors of the body [A32584]. Cannabinoid receptors are utilized endogenously by the body through the endocannabinoid system, which includes a group of lipid proteins, enzymes, and receptors that are involved in many physiological processes. Through its modulation of neurotransmitter release, the endocannabinoid system regulates cognition, pain sensation, appetite, memory, sleep, immune function, and mood among many other bodily systems. These effects are largely mediated through two members of the G-protein coupled receptor family, cannabinoid receptors 1 and 2 (CB1 and CB2)[A32585,A32824]. CB1 receptors are found in both the central and peripheral nervous systems, with the majority of receptors localized to the hippocampus and amygdala of the brain. Physiological effects of using cannabis make sense in the context of its receptor activity as the hippocampus and amygdala are primarily involved with regulation of memory, fear, and emotion. In contrast, CB2 receptors are mainly found peripherally in immune cells, lymphoid tissue, and peripheral nerve terminals [A32676].  Tetrahydrocannabinol (THC) and cannabidiol (CBD) are two types of cannabinoids found naturally in the resin of the marijuana plant, both of which interact with the cannabinoid receptors that are found throughout the body. Although THC and CBD have been the most studied cannabinoids, there are many others identified to date including cannabinol (CBN), cannabigerol (CBG), [DB14050] (CBDV), and [DB11755] (THCV) that can be found within the medical cannabis [A32830]. While both CBD and THC are used for medicinal purposes, they have different receptor activity, function, and physiological effects. If not provided in their activated form (such as through synthetic forms of THC like [DB00470] or [DB00486]), THC and CBD are obtained through conversion from their precursors, tetrahydrocannabinolic acid-A (THCA-A) and cannabidiolic acid (CBDA), through decarboxylation reactions. This can be achieved through heating, smoking, vaporization, or baking of dried unfertilized female cannabis flowers.  The primary psychoactive component of Cannabis, delta 9-tetrahydrocannabinol (Δ9-THC), demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors. This activity results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. In contrast to THC's weak agonist activity, CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body [A32469]. Allosteric regulation is achieved through the modulation of receptor activity on a functionally distinct site from the agonist or antagonist binding site which is clinically significant as direct agonists (such as THC) are limited by their psychomimetic effects such as changes to mood, memory, and anxiety[A32469].   In addition to the well-known activity on CB1 and CB2 receptors, there is further evidence that CBD also activates 5-HT1A/2A/3A serotonergic and TRPV1–2 vanilloid receptors, antagonizes alpha-1 adrenergic and µ-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gamma-aminobutyric acid (GABA), and cellular uptake of anandamide, acts on mitochondria Ca2+ stores, blocks low-voltage-activated (T-type) Ca2+ channels, stimulates activity of the inhibitory glycine-receptor, and inhibits activity of fatty amide hydrolase (FAAH) [A31555, A31574].  CBD is currently available in Canada within a 1:1 formulation with tetrahydrocannbinol (THC) (as the formulation known as "nabiximols") as the brand name product Sativex. It is approved for use as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis (MS). Sativex was also given a conditional Notice of Compliance (NOC/c) for use as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis and as adjunctive analgesic treatment for moderate to severe pain in adult patients with advanced cancer [L886].  In April 2018, a Food and Drug Administration advisory panel unanimously recommended approval of Epidiolex (cannabidiol oral solution) for the treatment of two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome, which are among the two most difficult types of epilepsy to treat [L2721, L2719]. Epidiolex was granted Orphan Drug designation as well as Fast Track Approval from the FDA for further study in these hard to treat conditions. Notably, phase 3 clinical trials of Epidiolex have demonstrated clinically significant improvement in Lennox-Gastaut syndrome and Dravet syndrome [L2720]. On June 25th, 2018, Epidiolex was approved by the FDA to be the first CBD-based product available on the US market.
;
_pdbe_chem_comp_drugbank_details.cas_number 13956-29-1
_pdbe_chem_comp_drugbank_details.mechanism_of_action
'The exact mechanism of action of CBD and THC is not currently fully understood. However, it is known that CBD acts on cannabinoid (CB) receptors of the endocannabinoid system, which are found in numerous areas of the body, including the peripheral and central nervous systems, including the brain. The endocannabinoid system regulates many physiological responses of the body including pain, memory, appetite, and mood. More specifically, CB1 receptors can be found within the pain pathways of the brain and spinal cord where they may affect CBD-induced analgesia and anxiolysis, and CB2 receptors have an effect on immune cells, where they may affect CBD-induced anti-inflammatory processes.   CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body [A32469]. Allosteric regulation of a receptor is achieved through the modulation of the activity of a receptor on a functionally distinct site from the agonist or antagonist binding site. The negative allosteric modulatory effects of CBD are therapeutically important as direct agonists are limited by their psychomimetic effects while direct antagonists are limited by their depressant effects [A32469].'
#
loop_
_pdbe_chem_comp_synonyms.comp_id
_pdbe_chem_comp_synonyms.name
_pdbe_chem_comp_synonyms.provenance
_pdbe_chem_comp_synonyms.type
P0T "(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol" wwPDB ?
P0T .DELTA.1(2)-TRANS-CANNABIDIOL DrugBank ?
P0T '(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol' DrugBank ?
P0T '(−)-trans-cannabidiol' DrugBank ?
P0T "(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol" DrugBank ?
P0T Cannabidiol DrugBank ?
P0T CBD DrugBank ?
P0T 'Δ1(2)-trans-cannabidiol' DrugBank ?
#
_pdbe_chem_comp_drugbank_classification.comp_id P0T
_pdbe_chem_comp_drugbank_classification.drugbank_id DB09061
_pdbe_chem_comp_drugbank_classification.parent 'Aromatic monoterpenoids'
_pdbe_chem_comp_drugbank_classification.kingdom 'Organic compounds'
_pdbe_chem_comp_drugbank_classification.class 'Prenol lipids'
_pdbe_chem_comp_drugbank_classification.superclass 'Lipids and lipid-like molecules'
_pdbe_chem_comp_drugbank_classification.description
'This compound belongs to the class of organic compounds known as aromatic monoterpenoids. These are monoterpenoids containing at least one aromatic ring.'
#
loop_
_pdbe_chem_comp_drugbank_targets.comp_id
_pdbe_chem_comp_drugbank_targets.drugbank_id
_pdbe_chem_comp_drugbank_targets.name
_pdbe_chem_comp_drugbank_targets.organism
_pdbe_chem_comp_drugbank_targets.uniprot_id
_pdbe_chem_comp_drugbank_targets.pharmacologically_active
_pdbe_chem_comp_drugbank_targets.ordinal
P0T DB09061 'Cannabinoid receptor 1' Humans P21554 yes 1
P0T DB09061 'Cannabinoid receptor 2' Humans P34972 yes 2
P0T DB09061 'G-protein coupled receptor 12' Humans P47775 unknown 3
P0T DB09061 'Glycine receptor subunit alpha-1' Humans P23415 unknown 4
P0T DB09061 'Glycine receptor subunit alpha-1' Humans P23415 unknown 5
P0T DB09061 'Glycine receptor subunit beta' Humans P48167 unknown 6
P0T DB09061 'Glycine receptor subunit alpha-3' Humans O75311 unknown 7
P0T DB09061 'N-arachidonyl glycine receptor' Humans Q14330 unknown 8
P0T DB09061 'G-protein coupled receptor 55' Humans Q9Y2T6 unknown 9
P0T DB09061 '5-hydroxytryptamine receptor 1A' Humans P08908 unknown 10
P0T DB09061 '5-hydroxytryptamine receptor 2A' Humans P28223 unknown 11
P0T DB09061 'Neuronal acetylcholine receptor subunit alpha-7' Humans P36544 unknown 12
P0T DB09061 'Delta-type opioid receptor' Humans P41143 unknown 13
P0T DB09061 'Mu-type opioid receptor' Humans P35372 unknown 14
P0T DB09061 'Peroxisome proliferator-activated receptor gamma' Humans P37231 unknown 15
P0T DB09061 'Transient receptor potential cation channel subfamily V member 1' Humans Q8NER1 unknown 16
P0T DB09061 'Voltage-dependent T-type calcium channel subunit alpha-1G' Humans O43497 unknown 17
P0T DB09061 'Voltage-dependent T-type calcium channel subunit alpha-1H' Humans O95180 unknown 18
P0T DB09061 'Voltage-dependent T-type calcium channel subunit alpha-1I' Humans Q9P0X4 unknown 19
P0T DB09061 'Transient receptor potential cation channel subfamily A member 1' Humans O75762 unknown 20
P0T DB09061 'Transient receptor potential cation channel subfamily M member 8' Humans Q7Z2W7 unknown 21
P0T DB09061 'Transient receptor potential cation channel subfamily V member 2' Humans Q9Y5S1 unknown 22
P0T DB09061 'Transient receptor potential cation channel subfamily V member 3' Humans Q8NET8 unknown 23
P0T DB09061 'Transient receptor potential cation channel subfamily V member 4' Humans Q9HBA0 unknown 24
P0T DB09061 'Non-selective voltage-gated ion channel VDAC1' Humans P21796 unknown 25
P0T DB09061 '5-hydroxytryptamine receptor 3A' Humans P46098 unknown 26
P0T DB09061 'Adenosine receptor A1' Humans P30542 unknown 27
P0T DB09061 'Prostaglandin G/H synthase 1' Humans P23219 unknown 28
P0T DB09061 'Prostaglandin G/H synthase 2' Humans P35354 unknown 29
P0T DB09061 'Acetyl-CoA acetyltransferase, mitochondrial' Humans P24752 unknown 30
P0T DB09061 'Steroid 17-alpha-hydroxylase/17,20 lyase' Humans P05093 unknown 31
P0T DB09061 '3-hydroxy-3-methylglutaryl-coenzyme A reductase' Humans P04035 unknown 32
P0T DB09061 'Glutathione reductase, mitochondrial' Humans P00390 unknown 33
P0T DB09061 'Glutathione peroxidase 1' Humans P07203 unknown 34
P0T DB09061 'Indoleamine 2,3-dioxygenase 1' Humans P14902 unknown 35
P0T DB09061 'NAD(P)H dehydrogenase [quinone] 1' Humans P15559 unknown 36
P0T DB09061 Catalase Humans P04040 unknown 37
P0T DB09061 'Superoxide dismutase [Cu-Zn]' Humans P00441 unknown 38
P0T DB09061 'Serotonin N-acetyltransferase' Humans Q16613 unknown 39
P0T DB09061 'N-acylethanolamine-hydrolyzing acid amidase' Humans Q02083 unknown 40
#
loop_
_software.name
_software.version
_software.description
rdkit 2025.03.3 'Core functionality.'
pdbeccdutils 1.0.0 'Wrapper to provide 2D templates and molecular fragments.'
#
loop_
_pdbe_chem_comp_atom_depiction.comp_id
_pdbe_chem_comp_atom_depiction.atom_id
_pdbe_chem_comp_atom_depiction.element
_pdbe_chem_comp_atom_depiction.model_Cartn_x
_pdbe_chem_comp_atom_depiction.model_Cartn_y
_pdbe_chem_comp_atom_depiction.pdbx_ordinal
P0T C10 C 9.180 4.760 1
P0T C11 C 5.104 1.500 2
P0T C12 C 7.702 1.500 3
P0T C13 C 3.805 6.750 4
P0T C14 C 10.144 3.611 5
P0T C03 C 7.702 4.500 6
P0T C04 C 6.404 3.750 7
P0T C05 C 7.702 6.000 8
P0T C06 C 6.404 6.750 9
P0T C07 C 5.104 4.500 10
P0T C08 C 6.404 2.250 11
P0T C09 C 5.104 6.000 12
P0T C15 C 6.404 -0.750 13
P0T C16 C 5.104 0.000 14
P0T C17 C 7.702 0.000 15
P0T C18 C 6.404 -2.250 16
P0T C19 C 9.693 6.170 17
P0T C20 C 5.104 -3.000 18
P0T C21 C 5.104 -4.500 19
P0T C22 C 3.805 -5.250 20
P0T C23 C 3.805 -6.750 21
P0T O01 O 3.805 2.250 22
P0T O02 O 9.180 1.240 23
#
loop_
_pdbe_chem_comp_bond_depiction.comp_id
_pdbe_chem_comp_bond_depiction.atom_id_1
_pdbe_chem_comp_bond_depiction.atom_id_2
_pdbe_chem_comp_bond_depiction.value_order
_pdbe_chem_comp_bond_depiction.bond_dir
_pdbe_chem_comp_bond_depiction.pdbx_ordinal
P0T C13 C09 SINGLE NONE 1
P0T C23 C22 SINGLE NONE 2
P0T C22 C21 SINGLE NONE 3
P0T C09 C06 SINGLE NONE 4
P0T C09 C07 DOUBLE NONE 5
P0T O01 C11 SINGLE NONE 6
P0T C06 C05 SINGLE NONE 7
P0T C07 C04 SINGLE NONE 8
P0T C21 C20 SINGLE NONE 9
P0T C20 C18 SINGLE NONE 10
P0T C16 C11 DOUBLE NONE 11
P0T C16 C15 SINGLE NONE 12
P0T C11 C08 SINGLE NONE 13
P0T C18 C15 SINGLE NONE 14
P0T C15 C17 DOUBLE NONE 15
P0T C04 C08 SINGLE BEGINDASH 16
P0T C08 C12 DOUBLE NONE 17
P0T C04 C03 SINGLE NONE 18
P0T C17 C12 SINGLE NONE 19
P0T C05 C03 SINGLE NONE 20
P0T C12 O02 SINGLE NONE 21
P0T C03 C10 SINGLE BEGINWEDGE 22
P0T C10 C19 DOUBLE NONE 23
P0T C10 C14 SINGLE NONE 24
#
loop_
_pdbe_chem_comp_substructure.comp_id
_pdbe_chem_comp_substructure.substructure_name
_pdbe_chem_comp_substructure.id
_pdbe_chem_comp_substructure.substructure_type
_pdbe_chem_comp_substructure.substructure_smiles
_pdbe_chem_comp_substructure.substructure_inchis
_pdbe_chem_comp_substructure.substructure_inchikeys
P0T MurckoScaffold S1 scaffold 'C1=C[C@@H](c2ccccc2)CCC1' InChI=1S/C12H14/c1-3-7-11(8-4-1)12-9-5-2-6-10-12/h1,3-5,7-9,12H,2,6,10H2/t12-/m1/s1 MUSXBUOOSTWNCY-GFCCVEGCSA-N
P0T phenyl F1 fragment c1ccccc1 InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H UHOVQNZJYSORNB-UHFFFAOYSA-N
#
loop_
_pdbe_chem_comp_substructure_mapping.comp_id
_pdbe_chem_comp_substructure_mapping.atom_id
_pdbe_chem_comp_substructure_mapping.substructure_id
_pdbe_chem_comp_substructure_mapping.substructure_ordinal
P0T C11 S1 1
P0T C12 S1 1
P0T C03 S1 1
P0T C04 S1 1
P0T C05 S1 1
P0T C06 S1 1
P0T C07 S1 1
P0T C08 S1 1
P0T C09 S1 1
P0T C15 S1 1
P0T C16 S1 1
P0T C17 S1 1
P0T C11 F1 1
P0T C16 F1 1
P0T C15 F1 1
P0T C17 F1 1
P0T C12 F1 1
P0T C08 F1 1
#
_pdbe_chem_comp_rdkit_properties.comp_id P0T
_pdbe_chem_comp_rdkit_properties.exactmw 314.225
_pdbe_chem_comp_rdkit_properties.amw 314.469
_pdbe_chem_comp_rdkit_properties.lipinskiHBA 2
_pdbe_chem_comp_rdkit_properties.lipinskiHBD 2
_pdbe_chem_comp_rdkit_properties.NumRotatableBonds 11
_pdbe_chem_comp_rdkit_properties.NumHBD 2
_pdbe_chem_comp_rdkit_properties.NumHBA 2
_pdbe_chem_comp_rdkit_properties.NumHeavyAtoms 23
_pdbe_chem_comp_rdkit_properties.NumAtoms 53
_pdbe_chem_comp_rdkit_properties.NumHeteroatoms 2
_pdbe_chem_comp_rdkit_properties.NumAmideBonds 0
_pdbe_chem_comp_rdkit_properties.FractionCSP3 0.524
_pdbe_chem_comp_rdkit_properties.NumRings 2
_pdbe_chem_comp_rdkit_properties.NumAromaticRings 1
_pdbe_chem_comp_rdkit_properties.NumAliphaticRings 1
_pdbe_chem_comp_rdkit_properties.NumSaturatedRings 0
_pdbe_chem_comp_rdkit_properties.NumHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles 0
_pdbe_chem_comp_rdkit_properties.NumSpiroAtoms 0
_pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms 0
_pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters 2
_pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters 0
_pdbe_chem_comp_rdkit_properties.labuteASA 182.431
_pdbe_chem_comp_rdkit_properties.tpsa 40.460
_pdbe_chem_comp_rdkit_properties.CrippenClogP 4.812
_pdbe_chem_comp_rdkit_properties.CrippenMR 95.285
_pdbe_chem_comp_rdkit_properties.chi0v 11.316
_pdbe_chem_comp_rdkit_properties.chi1v 5.908
_pdbe_chem_comp_rdkit_properties.chi2v 2.556
_pdbe_chem_comp_rdkit_properties.chi3v 2.556
_pdbe_chem_comp_rdkit_properties.chi4v 1.682
_pdbe_chem_comp_rdkit_properties.chi0n 41.316
_pdbe_chem_comp_rdkit_properties.chi1n 20.725
_pdbe_chem_comp_rdkit_properties.chi2n 2.556
_pdbe_chem_comp_rdkit_properties.chi3n 2.556
_pdbe_chem_comp_rdkit_properties.chi4n 1.682
_pdbe_chem_comp_rdkit_properties.hallKierAlpha -1.700
_pdbe_chem_comp_rdkit_properties.kappa1 3.209
_pdbe_chem_comp_rdkit_properties.kappa2 7.718
_pdbe_chem_comp_rdkit_properties.kappa3 4.186
_pdbe_chem_comp_rdkit_properties.Phi 1.077
#
loop_
_pdbe_chem_comp_external_mappings.comp_id
_pdbe_chem_comp_external_mappings.source
_pdbe_chem_comp_external_mappings.resource
_pdbe_chem_comp_external_mappings.resource_id
P0T UniChem DrugBank DB09061
P0T UniChem 'Guide to Pharmacology' 4150
P0T UniChem 'PubChem DOTF' 12012585
P0T UniChem ChEBI 69478
P0T UniChem ZINC ZINC000004097406
P0T UniChem fdasrs 19GBJ60SN5
P0T UniChem 'PubChem TPHARMA' 14899058
P0T UniChem NMRShiftDB 60019489
P0T UniChem BindingDb 50318484
P0T UniChem DrugCentral 5288
P0T UniChem MetaboLights MTBLC69478
P0T UniChem BRENDA 62441
P0T UniChem ChemicalBook CB7673434
P0T UniChem DailyMed CANNABIDIOL
P0T UniChem ClinicalTrials BTX-1204
P0T UniChem ClinicalTrials BTX-1503
P0T UniChem ClinicalTrials CANNABIDIOL
P0T UniChem ClinicalTrials 'CANNABIDIOL SOLUTION'
P0T UniChem ClinicalTrials CARDIOLRX
P0T UniChem ClinicalTrials EPIDIOLEX
P0T UniChem ClinicalTrials GWP-42003
P0T UniChem ClinicalTrials GWP-42003-P
P0T UniChem ClinicalTrials GWP42003
P0T UniChem ClinicalTrials GWP42003-P
P0T UniChem rxnorm CANNABIDIOL
P0T UniChem rxnorm EPIDIOLEX
P0T UniChem 'Probes And Drugs' PD016236
P0T UniChem CCDC CANDOM
P0T UniChem LipidMaps LMPK13120005
P0T UniChem eMolecules 536311
P0T UniChem SureChEMBL SCHEMBL119679
P0T UniChem 'PubChem TPHARMA' 14825860
P0T UniChem PubChem 644019
P0T UniChem ACTor 13956-29-1
P0T UniChem Nikkaji J10.356J
P0T UniChem BindingDb 50121429
#
loop_
_pdbe_chem_comp_rdkit_conformer.comp_id
_pdbe_chem_comp_rdkit_conformer.atom_id
_pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit
_pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit
_pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit
_pdbe_chem_comp_rdkit_conformer.rdkit_method
_pdbe_chem_comp_rdkit_conformer.rdkit_ordinal
P0T C10 -2.817 -1.820 1.003 ETKDGv3 1
P0T C11 0.547 -1.132 0.036 ETKDGv3 2
P0T C12 -0.339 1.129 0.430 ETKDGv3 3
P0T C13 -3.549 2.098 -3.314 ETKDGv3 4
P0T C14 -2.563 -1.657 2.479 ETKDGv3 5
P0T C03 -3.007 -0.590 0.122 ETKDGv3 6
P0T C04 -1.832 -0.406 -0.875 ETKDGv3 7
P0T C05 -4.344 -0.639 -0.637 ETKDGv3 8
P0T C06 -4.568 0.674 -1.392 ETKDGv3 9
P0T C07 -2.123 0.644 -1.933 ETKDGv3 10
P0T C08 -0.529 -0.092 -0.136 ETKDGv3 11
P0T C09 -3.367 1.082 -2.220 ETKDGv3 12
P0T C15 1.883 0.520 1.267 ETKDGv3 13
P0T C16 1.676 -0.823 0.688 ETKDGv3 14
P0T C17 0.916 1.439 1.147 ETKDGv3 15
P0T C18 3.175 0.852 1.973 ETKDGv3 16
P0T C19 -2.853 -3.062 0.490 ETKDGv3 17
P0T C20 4.078 1.770 1.134 ETKDGv3 18
P0T C21 4.597 1.134 -0.172 ETKDGv3 19
P0T C22 5.799 0.186 0.025 ETKDGv3 20
P0T C23 5.403 -1.289 0.056 ETKDGv3 21
P0T O01 0.433 -2.439 -0.446 ETKDGv3 22
P0T O02 -1.319 2.118 0.345 ETKDGv3 23
P0T H1 -2.931 2.996 -3.101 ETKDGv3 24
P0T H2 -3.237 1.662 -4.286 ETKDGv3 25
P0T H3 -4.610 2.415 -3.393 ETKDGv3 26
P0T H4 -3.370 -2.156 3.056 ETKDGv3 27
P0T H5 -2.531 -0.588 2.776 ETKDGv3 28
P0T H6 -1.587 -2.116 2.744 ETKDGv3 29
P0T H7 -3.055 0.306 0.778 ETKDGv3 30
P0T H8 -1.733 -1.333 -1.464 ETKDGv3 31
P0T H9 -4.350 -1.478 -1.367 ETKDGv3 32
P0T H10 -5.181 -0.794 0.078 ETKDGv3 33
P0T H11 -5.456 0.557 -2.051 ETKDGv3 34
P0T H12 -4.788 1.485 -0.664 ETKDGv3 35
P0T H13 -1.291 0.980 -2.548 ETKDGv3 36
P0T H16 2.442 -1.577 0.808 ETKDGv3 37
P0T H17 1.050 2.427 1.571 ETKDGv3 38
P0T H18 2.936 1.372 2.927 ETKDGv3 39
P0T H19 3.720 -0.069 2.258 ETKDGv3 40
P0T H20 -2.709 -3.929 1.128 ETKDGv3 41
P0T H21 -3.015 -3.233 -0.568 ETKDGv3 42
P0T H22 4.937 2.103 1.756 ETKDGv3 43
P0T H23 3.508 2.689 0.875 ETKDGv3 44
P0T H24 3.773 0.637 -0.728 ETKDGv3 45
P0T H25 4.938 1.970 -0.822 ETKDGv3 46
P0T H26 6.366 0.438 0.947 ETKDGv3 47
P0T H27 6.497 0.323 -0.831 ETKDGv3 48
P0T H28 4.785 -1.549 -0.830 ETKDGv3 49
P0T H29 4.846 -1.532 0.980 ETKDGv3 50
P0T H30 6.319 -1.916 0.039 ETKDGv3 51
P0T H31 -0.383 -2.816 -0.901 ETKDGv3 52
P0T H32 -1.187 3.032 0.762 ETKDGv3 53
#